Page 94 - 75_01
P. 94
Mariano Esteban Rodríguez An. R. Acad. Nac. Farm.
15. Fauci, A.S., Johnston, M.I., Dieffenbach, C.W., Burton, D.R., Hammer, S.M., Hoxie,
J.A., et al. (2008) HIV vaccine research: the way forward. Science. 321: 530-2.
16. Gomez, C.E., Najera, J.L., Jimenez, V., Bieler, K., Wild, J., Kostic, L., et al. (2007)
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting
HIV-1 Env/Gag-Pol-Nef antigens of clade C. Vaccine. 25: 1969-92.
17. Mooij, P., Balla-Jhagjhoorsingh, S.S., Koopman, G., Beenhakker, N., van Haaften,
P., Baak, I., et al. (2008) Differential CD4+ versus CD8+ T-cell responses elicited
by different poxvirus-based human immunodeficiency virus type 1 vaccine can-
didates provide comparable efficacies in primates. J. Virol. 82: 2975-88.
18. Harari, A., Bart, P.A., Stohr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., et al.
(2008) An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces re-
liable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205: 63-77.
19. Corbett, M., Bogers, W.M., Heeney, J.L., Gerber, S., Genin, C., Didierlaurent, A.,
et al. (2008) Aerosol immunization with NYVAC and MVA vectored vaccines is
safe, simple, and immunogenic. Proc. Natl. Acad. Sci. U S A. 105: 2046-51.
20. Watkins, D.I., Burton, D.R., Kallas, E.G., Moore, J.P. & Koff, W.C. (2008)
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in hu-
mans. Nat. Med. 14:617-21.
21. Barouch, D.H. (2008) Challenges in the development of an HIV-1 vaccine. Nature.
455: 613-9.
22. Ikenberg, H., Gissmann, L., Gross, G., Grussendorf-Conen, E.I. & zur Hausen,
H. (1983) Human papillomavirus type-16-related DNA in genital Bowen’s disea-
se and in Bowenoid papulosis. Int. J. Cancer. 32: 563-5.
23. Boshart, M., Gissmann, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W. & zur
Hausen, H. (1984) A new type of papillomavirus DNA, its presence in genital can-
cer biopsies and in cell lines derived from cervical cancer. Embo J. 3: 1151-7.
24. Woodman, C.B., Collins, S.I. & Young, L.S. (2007) The natural history of cervi-
cal HPV infection: unresolved issues. Nat. Rev. Cancer. 7: 11-22.
25. Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau,
A., et al. (1985) Structure and transcription of human papillomavirus sequences
in cervical carcinoma cells. Nature. 314: 111-4.
26. Koutsky, L.A. & Harper, D.M. (2006) Chapter 13: Current findings from prophy-
lactic HPV vaccine trials. Vaccine. 24 Suppl 3: S3/114-21.
27. Schiller, J.T., Castellsague, X., Villa, L.L. & Hildesheim, A. (2008) An update of
prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial re-
sults. Vaccine. 26 Suppl 10: K53-61.
98
